The story read more of Viagra, and its parent company copyright, presents a intriguing case study for investors. Originally a blockbuster drug, generating billions in revenue , its intellectual property lapse created a deluge of generic competition , significantly diminishing its position . While specific businesses may try to capitalize on similar